Working… Menu

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) (PROMINENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03071692
Recruitment Status : Recruiting
First Posted : March 7, 2017
Last Update Posted : February 21, 2019
Brigham and Women's Hospital
Information provided by (Responsible Party):
Kowa Research Institute, Inc.